Premium
Synthesis of Analogues of BCTC Incorporating a Pyrrolidinyl Linker and Biological Evaluation as Transient Receptor Potential Vanilloid 1 Antagonists
Author(s) -
Yan Lin,
Wang Jingjie,
Pan Miaobo,
Qiu Qianqian,
Huang Wenlong,
Qian Hai
Publication year - 2016
Publication title -
chemical biology and drug design
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 77
eISSN - 1747-0285
pISSN - 1747-0277
DOI - 10.1111/cbdd.12661
Subject(s) - antagonism , trpv1 , antagonist , linker , chemistry , capsaicin , in vivo , analgesic , transient receptor potential channel , pharmacology , in vitro , receptor , biochemistry , biology , microbiology and biotechnology , computer science , operating system
A series of novel pyrrolidinyl linker TRPV 1 antagonists were prepared in an effort to lower the hyperthermic side‐effects of first‐generation antagonist BCTC . These compounds were investigated for antagonism of h TRPV 1 activation by capsaicin and acid in vitro . Preliminary results suggested the compounds 10a , 10b , 10c and 10j had favorable TRPV 1 antagonism activity. In further studies in vivo , 10b , comparable to BCTC , showed potent analgesic activity in capsaicin‐induced and heat‐induced pain models. In addition, 10b indicated a reduced risk of body temperature elevation. All of these demonstrated that 10b can be considered as a safe candidate for the further development of analgesic drugs.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom